Pharma crimes:
Ann Kristin Ulrichsen, [01.01.2022 21:14]
[Forwarded from LastManStanding]
This is what he is speaking about. I posted this months ago.
Pfizer
Pfizer fined biggest criminal fine in history for mispromoting medicines and for paying
kickbacks to complaint doctors. Fined $2.3 billion
https://www.theguardian.com/business/2009/sep/02/pfizer-drugs-us-criminal-fine
Pfizer fined for paying bribes.
https://www.dawn.com/news/740499/pfizer-fined-for-paying-bribes-overseas
Reports on Pfizer Drug Studies Misleading.
https://medicalxpress.com/news/2009-11-pfizer-drug.html
(https://medicalxpress.com/news/2009-11-pfizer-drug.html)
Pfizer fined for over charging NHS
(https://www.independent.co.uk/news/business/news/pfizer-flynn-pharma-fined-prices-drugs-nhs-cma-a7460266.html)
Pfizer pays out to Nigerian families of meningitis drug trial victims
https://www.theguardian.com/world/2011/aug/11/pfizer-nigeria-meningitis-drug-compensation
Pfizer admits bribery in eight countries
https://corpwatch.org/article/pfizer-admits-bribery-eight-countries
(https://corpwatch.org/article/pfizer-admits-bribery-eight-countries)
2012, 26 Global Pharmaceutical companies fined £11 billion including 8 out of the top 10, for dishonesty, Including GlaxoSmithKline fined £3 billion.
(https://www.independent.co.uk/life-style/health-and-families/health-news/drug-giants-fined-11bn-criminal-wrongdoing-8157483.html)
Pfizer fined $60million for bribing doctors
Pfizer fined $14.5million for illegal marketing of the drug Detrol
https://www.justice.gov/opa/pr/pfizer-pay-145-million-illegal-marketing-drug-detrol
(https://www.justice.gov/opa/pr/pfizer-pay-145-million-illegal-marketing-drug-detrol)
Company Wyeth acquired by Pfizer in 2009 fine $490 million in 2013 for putting profit before safety
(https://www.news.com.au/world/breaking-news/wyeth-fined-us490m-for-illegal-marketing/news-story/87be7b3cd137cb63293fb0986ac27555)
2010 Nigeria sues Pfizer for 7 billion for illegal tests on children.
https://www.dntghana.com/2020/11/11/nigeria-sues-pfizer-for-7bn-over-illegal-tests-on-children/ (https://www.dntghana.com/2020/11/11/nigeria-sues-pfizer-for-7bn-over-illegal-tests-on-children/)
AstraZeneca
2005 Fined £40million for misleading government agencies and blocking copies of drugs
https://www.theguardian.com/business/2005/jun/16/health.society
Advertising and Marketing Controversies
In 2003 federal officials announced (http://www.justice.gov/opa/pr/2003/June/03_civ_371.htm) that AstraZeneca had pleaded guilty to criminal and civil charges relating to the illegal marketing of the prostate cancer drug Zoladex. The company agreed to pay $355 million, consisting of $64 million in criminal fines, a $266 million settlement of civil False Claims Act charges, and a $25 million settlement of fraud charges relating to state Medicaid programs. AstraZeneca, which agreed to enter into a corporate integrity agreement with the Inspector General of the U.S. Department of Health and Human Services, had been accused of giving illegal financial inducements such as grants and honoraria to physicians.
In 2004 a coalition of consumer groups filed suit (http://query.nytimes.com/gst/fullpage.html?res=9F0CE2D6123AF93AA25753C1A9629C8B63) against AstraZeneca in a California state court, arguing that advertising for the company’s acid reflux drug Nexium misled consumers into thinking that it was superior to AstraZeneca’s Prilosec. The company had introduced Nexium to replace Prilosec as the latter drug was losing its patent protection. The case, along with a related one filed in Massachusetts, is pending (http://www.prescriptionaccess.org/lawsuitssettlements/current_lawsuits?id=0019).
Also in 2004, the U.S. Food and Drug Administration (FDA) found (http://select.nytimes.com/gst/abstract.html?res=F40810FF3A540C708EDDAB0994DC404482) that AstraZeneca’s full-page newspaper advertisements defending the safety of its Crestor cholesterol medication were “false and misleading.” The warning letter (http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/ucm054657.pdf) sent by the agency to AstraZeneca took issue not only with what the company said about the drug but also the way it represented the FDA’s position on Crestor.
In 2010 the U.S. Justice Department announced (http://www.justice.gov/opa/pr/2010/April/10-civ-487.html) that AstraZeneca would pay $520 million to resolve allegations that it illegally marketed its anti-psychotic drug Seroquel for uses not approved as safe and effective by the FDA. Under the terms of the settlement, $302 million of the total was to go to the federal government and $218 million to state Medicaid programs.